Joshua E. Freeman

Array ( [id] => 4486118 [patent_doc_number] => 07902401 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-03-08 [patent_title] => 'Fluorinated compounds' [patent_app_type] => utility [patent_app_number] => 11/610864 [patent_app_country] => US [patent_app_date] => 2006-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14929 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/902/07902401.pdf [firstpage_image] =>[orig_patent_app_number] => 11610864 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5166132 [patent_doc_number] => 20070287719 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Salts, Prodrugs and Formulations of 1-[5-(4-Amino-7-Isopropyl-7H-Pyrrolo[2,3-D]Pyrimidine-5-Carbonyl)-2-Methoxy-Phenyl]-3-(2,4-Dichloro-Phenyl)-Urea' [patent_app_type] => utility [patent_app_number] => 11/608551 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 36987 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 37 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20070287719.pdf [firstpage_image] =>[orig_patent_app_number] => 11608551 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8283100 [patent_doc_number] => 08217200 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-07-10 [patent_title] => 'Process for the preparation of 2-chloroethoxy-acetic acid-N,N-dimethylamide' [patent_app_type] => utility [patent_app_number] => 12/096616 [patent_app_country] => US [patent_app_date] => 2006-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2813 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12096616 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 252870 [patent_doc_number] => 07579504 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'ABCA1 elevating compounds' [patent_app_type] => utility [patent_app_number] => 11/635905 [patent_app_country] => US [patent_app_date] => 2006-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17618 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579504.pdf [firstpage_image] =>[orig_patent_app_number] => 11635905 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359874 [patent_doc_number] => 07485753 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Contrast agents' [patent_app_type] => utility [patent_app_number] => 11/565673 [patent_app_country] => US [patent_app_date] => 2006-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3292 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485753.pdf [firstpage_image] =>[orig_patent_app_number] => 11565673 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8690236 [patent_doc_number] => 08389765 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-05 [patent_title] => 'Purification of iodixanol' [patent_app_type] => utility [patent_app_number] => 12/094500 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2969 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 115 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12094500 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5253951 [patent_doc_number] => 20070135407 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Serm reduction of lipid profiles' [patent_app_type] => utility [patent_app_number] => 11/604897 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 8879 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135407.pdf [firstpage_image] =>[orig_patent_app_number] => 11604897 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5324351 [patent_doc_number] => 20090062341 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Nuclear receptor binding agents' [patent_app_type] => utility [patent_app_number] => 11/604884 [patent_app_country] => US [patent_app_date] => 2006-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 53513 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0062/20090062341.pdf [firstpage_image] =>[orig_patent_app_number] => 11604884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5546805 [patent_doc_number] => 20090156682 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'N-(1-Methyl-2Phenylethyl)Benzamide Derivatives' [patent_app_type] => utility [patent_app_number] => 12/085300 [patent_app_country] => US [patent_app_date] => 2006-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7076 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20090156682.pdf [firstpage_image] =>[orig_patent_app_number] => 12085300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4860492 [patent_doc_number] => 20080269342 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-30 [patent_title] => 'Pleuromutilin Derivatives and Its Use' [patent_app_type] => utility [patent_app_number] => 12/093729 [patent_app_country] => US [patent_app_date] => 2006-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9134 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0269/20080269342.pdf [firstpage_image] =>[orig_patent_app_number] => 12093729 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983475 [patent_doc_number] => 20070088034 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Oxo-substituted cyclohexyl-1,4-diamine compounds' [patent_app_type] => utility [patent_app_number] => 11/594952 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8485 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20070088034.pdf [firstpage_image] =>[orig_patent_app_number] => 11594952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 907743 [patent_doc_number] => 07332608 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-02-19 [patent_title] => 'Anthranilamides and methods of their use' [patent_app_type] => utility [patent_app_number] => 11/558132 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11304 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/332/07332608.pdf [firstpage_image] =>[orig_patent_app_number] => 11558132 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5183723 [patent_doc_number] => 20070055077 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-03-08 [patent_title] => 'CHEMICAL PROCESS' [patent_app_type] => utility [patent_app_number] => 11/554076 [patent_app_country] => US [patent_app_date] => 2006-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5161 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0055/20070055077.pdf [firstpage_image] =>[orig_patent_app_number] => 11554076 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4682956 [patent_doc_number] => 20080249182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Crystalline Modification of N-Ethyl-2,2-Dichloro-1-Methylcyclopropane-Carboxamide-2-(2,6-Dichloro-Alpha, Alpha, Alpha-Trifluoro-P-Tolyl)Hydrazone' [patent_app_type] => utility [patent_app_number] => 12/090733 [patent_app_country] => US [patent_app_date] => 2006-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13061 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249182.pdf [firstpage_image] =>[orig_patent_app_number] => 12090733 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4853337 [patent_doc_number] => 20080319080 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Amide Compounds and Their Use' [patent_app_type] => utility [patent_app_number] => 12/084129 [patent_app_country] => US [patent_app_date] => 2006-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23479 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0319/20080319080.pdf [firstpage_image] =>[orig_patent_app_number] => 12084129 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4530718 [patent_doc_number] => 07923578 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-04-12 [patent_title] => 'Method of manufacturing 3-(4-hydroxyphenyl)propanoic acid amide, its application in the manufacture of anti-aging compositions and anti-aging composition' [patent_app_type] => utility [patent_app_number] => 12/090768 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 4850 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 13 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/923/07923578.pdf [firstpage_image] =>[orig_patent_app_number] => 12090768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983456 [patent_doc_number] => 20070088015 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'Non-nucleoside reverse transcriptase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/583345 [patent_app_country] => US [patent_app_date] => 2006-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24946 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20070088015.pdf [firstpage_image] =>[orig_patent_app_number] => 11583345 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5035615 [patent_doc_number] => 20070100154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-03 [patent_title] => 'Process for the production of acid chlorides' [patent_app_type] => utility [patent_app_number] => 11/582000 [patent_app_country] => US [patent_app_date] => 2006-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1846 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0100/20070100154.pdf [firstpage_image] =>[orig_patent_app_number] => 11582000 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5515739 [patent_doc_number] => 20090216046 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-08-27 [patent_title] => 'SELECTIVE ACYLATION OF 4-SUBSTITUTED-1,3-PHENYLENEDIAMINE' [patent_app_type] => utility [patent_app_number] => 12/091352 [patent_app_country] => US [patent_app_date] => 2006-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2628 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20090216046.pdf [firstpage_image] =>[orig_patent_app_number] => 12091352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5570294 [patent_doc_number] => 20090253672 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-08 [patent_title] => 'Cathepsin Cysteine Protease Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/083474 [patent_app_country] => US [patent_app_date] => 2006-10-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13309 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20090253672.pdf [firstpage_image] =>[orig_patent_app_number] => 12083474 [rel_patent_id] =>[rel_patent_doc_number] =>)